Cytology is a branch of pathology that deals with the study of physical, chemical, and functional characters of cells. Cytology is one of the leading diagnostic methods used for detection of cancer. Cytology collection involves extracting cells from various body parts by using specialized devices. These specimens are further processed by cytology testing devices in pathology laboratories to evaluate the presence of a disease. Cytology specimens are collected from body parts such as the oral cavity, the gastrointestinal tract, the cervical tract, and the respiratory tract and from plural fluid, pericardial fluid, and spinal fluid. Most of the cytology collection techniques are non-invasive; however, some apply invasive or surgical techniques to collect the specimen. Selection of the cytology device depends on the application area and specimen requirements.
Cancer detection is one of the widely applied areas of cytology. According to the World Health Organization (WHO), 14 million new cancer cases were diagnosed in 2012 and the number of new cases is estimated to rise by 70% by 2035. High prevalence of cancer across the globe is estimated to increase the adoption of cytology devices for conducting cytology tests. Technical advancements in the field of cytology such as automated cytology analyzers and point-of-care testing devices are estimated to fuel the cytology devices market during the forecast period. Increasing efficiency and availability of advanced collection devices such as aspiration needles for collection of liver and pancreas specimens is projected to propel the cytology devices market from 2017 to 2025. However, availability of low-quality and inexpensive cytology devices in regional marketplaces is anticipated to hamper the cytology devices market. Moreover, developments in alternative therapies such as immunoassays and molecular diagnostics is likely to hamper the market from 2017 to 2025.
The global cytology devices market can be segmented based on product, application, end-user, and region. In terms of product, the market can be divided into brushes, spatulas, aspiration needles, and others. The brushes segment can be sub-divided into metallic and plastic brushes. The others segment comprises cytology devices such as currets and cervical brooms. The brushes segment is anticipated to hold a leading share of the global cytology devices market from 2017 to 2025. The aspiration needles segment is anticipated to witness high growth during the forecast period, owing to their rising usage in the collection of liver, pancreas, and breast specimens as well as plural fluids and spinal fluids. Based on application, the global cytology devices market can be segmented into pulmonology, gastroenterology, gynecology, and others. High prevalence of cervical cancer and launch of new products for the treatment of cervical cancer are factors estimated to fuel the gynecology segment during the forecast period. Technological advancements in the field of gastroenterology such as new endoscopy systems and ultrasound endoscopy are projected to contribute to high growth of the gastroenterology segment. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. The diagnostic laboratories segment is likely to account for a leading share of the global cytology devices market during the forecast period>
Geographically, the global cytology devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to constitute a leading share of the global market during the forecast period, owing to high number of cytology tests being performed in the region. Europe is anticipated to account for a significant share of the global market between 2017 and 2025. According to the World Health Organization (WHO), around 3.7 million new cases of cancer were registered in Europe in 2012. The market in Asia Pacific is projected to witness high growth during the forecast period, owing to increasing health care expenditure in the region.
Major players operating in the global cytology devices market are Biocytech Corporation, RI.MOS. srl, CONMED Corporation, Olympus Corporation, MEDI-GLOBE CORPORATION, US Endoscopy (a part of STERIS Corporation), ENDO-FLEX GmbH, Nipro, and STERYLAB S.r.l.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.